C0003153479P
This role involves leading Health Economics and Outcomes Research (HEOR) evidence strategies to support market access and reimbursement for priority assets in Japan. The position requires serving as a trusted senior expert to provide decision-oriented recommendations to local and global stakeholders while shaping evidence generation plans across the product lifecycle. The role focuses on translating evidence into decisions through health economics, outcomes research, and real-world evidence to influence cross-functional decisions and build external partnerships.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for C0003153479P.
C0003153479P didn’t post a salary, so this is our estimate from similar listings.
Associate Director, HEOR Japan
Revolution Medicines
Director, HEOR Strategy, Global Immunology Pipeline
AbbVie
Executive Director, Health Economics & Outcomes Research (HEOR)
Travere Therapeutics
Director Global HEOR
Sobi
Executive Director, HEOR, Europe
Revolution Medicines
Lead, Health Economics & Outcomes Research (HEOR)
Novartis